Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Visa Honkanen"'
Autor:
Kati P Markula-Patjas, Liisa Kerttula, Irma H Soini, Visa Honkanen, Outi Mäkitie, Sanna-Maria Toiviainen-Salo, Helena L Valta
Publikováno v:
The Journal of Rheumatology. 39:365-373
Objective.Vertebral fractures occur in patients with juvenile idiopathic arthritis (JIA), but data on their frequency and causes are scarce. Our cross-sectional study evaluated prevalence of compression fractures and associated factors in a high-risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd70efff32f057e43991c16be2090e60
https://doi.org/10.3899/jrheum.110305
https://doi.org/10.3899/jrheum.110305
Autor:
Erkki Komulainen, Yrjö T. Konttinen, Visa Honkanen, Katariina Tamm, Hanna Vuorimaa, Nina Santavirta
Publikováno v:
Children's Health Care. 40:34-52
The purpose of this study was to identify the associations between parental and child psychosocial factors and pain in juvenile idiopathic arthritis (JIA). The sample comprised 142 patients with JIA and the attending parent. Explorative factor analys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5862bc57dfdfde870635cff301927d8
https://doi.org/10.1080/02739615.2011.537937
https://doi.org/10.1080/02739615.2011.537937
Publikováno v:
Annals of the Rheumatic Diseases. 68:552-557
Objectives:To evaluate drug survival (continuation rates on drug) of anti-tumour necrosis factor (TNF) agents in juvenile idiopathic arthritis (JIA) and predictors for treatment discontinuation.Methods:A retrospective observational study on JIA patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01fe3408333519c15491b7551f32b11c
https://doi.org/10.1136/ard.2007.087130
https://doi.org/10.1136/ard.2007.087130
Autor:
K Kotaniemi, Kristiina Aalto, Pekka Lahdenne, Pirjo Tynjälä, Katariina Latva, Visa Honkanen, P Lindahl
Publikováno v:
Rheumatology. 47:339-344
Objective. To evaluate the efficacy of adalimumab in juvenile idiopathic arthritis (JIA)-associated uveitis. Methods. Retrospective observational study of 20 patients with JIA and chronic uveitis on adalimumab treatment. The ocular inflammation and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fadf3376bbcdaf0bb4249f1b60d101c6
https://doi.org/10.1093/rheumatology/kem356
https://doi.org/10.1093/rheumatology/kem356
Publikováno v:
Annals of the Rheumatic Diseases. 65:1044-1049
To evaluate the impact of anti-tumour necrosis factor (TNF) treatment on growth and to identify the predictors for the change in growth in severe juvenile idiopathic arthritis (JIA).Data from 71 JIA patients (43 on etanercept, 28 on infliximab) were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9decb02425d8ab79db50d4ad460b4d92
https://doi.org/10.1136/ard.2005.047225
https://doi.org/10.1136/ard.2005.047225
Biological treatment in rheumatic diseases: results from a longitudinal surveillance: adverse events
Autor:
J. Pöllänen, M. Romu, M. Vasala, M. Waahtera, L. Konttinen, Anna Karjalainen, R. Luukkainen, Kari Puolakka, T. Uotila, Visa Honkanen, Dan Nordström
Publikováno v:
Rheumatology International. 26:916-922
The objective of this study was to assess the long-term safety and tolerability of biologicals in a clinical setting. Data on adverse events (AEs) have been collected over a 5-year period by means of detailed reports sent in to the National Register
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e126b68326599dd9eb4073c9b91cb47
https://doi.org/10.1007/s00296-005-0097-9
https://doi.org/10.1007/s00296-005-0097-9
Publikováno v:
Annals of the Rheumatic Diseases. 66:548-550
Objective: To evaluate the efficacy of anti-tumour necrosis factor (anti-TNF) treatment in juvenile idiopathic arthritis (JIA)-associated uveitis. Methods: 24 patients with uveitis taking etanercept and 21 taking infliximab were studied. The endpoint
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aedf858362ce6e8843410a24b6e92b6a
https://doi.org/10.1136/ard.2006.058248
https://doi.org/10.1136/ard.2006.058248
Publikováno v:
Rheumatology International. 14:231-234
In rheumatoid arthritis various pro-inflammatory metabolites of arachidonic acid (AA), such as leukotriene B4 (LTB4) and prostaglandin E2 (PGE2), contribute to tissue destruction and pain. In contrast to AA, which is an omega-6 fatty acid, the omega-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2958a2349a0e782307371956d585e487
https://doi.org/10.1007/bf00262088
https://doi.org/10.1007/bf00262088
Autor:
O Vaarala, M Sidoroff, Olli A. Jänne, Visa Honkanen, K-L Kolho, Taneli Raivio, H Rintamäki, K Tamm
Publikováno v:
Scandinavian journal of rheumatology. 40(5)
To study the systemic effects of intra-articular (IA) glucocorticoid (GC) injections in juvenile idiopathic arthritis (JIA).The study group comprised 21 JIA patients being treated with IA methylprednisolone [MP (n = 15) or MP plus triamcinolone hexac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b13bcf8e9ee472036d2ef9e7445bfee4
https://pubmed.ncbi.nlm.nih.gov/21619491
https://pubmed.ncbi.nlm.nih.gov/21619491
Autor:
Paula Vähäsalo, Pekka Lahdenne, Liisa Kröger, Kristiina Aalto, Maarit Tarkiainen, Visa Honkanen, Pirjo Tynjälä, Anne Putto-Laurila, Merja Malin
Publikováno v:
Annals of the rheumatic diseases. 70(9)
In juvenile idiopathic arthritis (JIA), the efficacy of very early disease-modifying drug therapy, synthetic or biological, is not well known. Three alternative strategies were compared for treating recent-onset polyarticular JIA.In a 54-week multice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c08442ade834d46087e9a07cea7decc0
https://pubmed.ncbi.nlm.nih.gov/21623000
https://pubmed.ncbi.nlm.nih.gov/21623000